Delivery Order SPE2DB24D1201-SPE2DB24FJAKE

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Eliquis 5 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $7,739.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract is a delivery order issued under Amerisourcebergen's...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $10,374.53, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, with an ultimate completion date of August 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $27,704.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $4,150.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 1, 2024, with an ultimate completion date of August 2, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
The federal contract award summarized is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $17,691.29, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $13,271.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $7,428.83, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $5,279.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 24, 2024. The contract is not designated with a set-aside and represents an open competition award. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distribution company, for a ceiling value of $12,438.63. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a value of $35,522.87 and runs through July 1, 2024. It is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJAKE
    Delivery Order

This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $16,209.63, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 3, 2024.

Generated 10/1/24, 11:12 AM